Vaxart, Inc.To Present At Phacilitate’s VAX 1-2-1 In Amsterdam On May 20, 2015

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vaxart, Inc., a privately held, clinical-stage company developing vaccines that are administered by tablet rather than by injection, today announced that Vaxart CEO Wouter Latour, MD, will present a corporate overview at Phacilitate’s VAX 1-2-1 in Amsterdam on Wednesday, May 20, 2015 at 3:30pm Central European Time. Dr. Latour will also take part in a panel discussion on vaccines on the same day, and he will be available to participate in one-on-one meetings during the meeting.

Help employers find you! Check out all the jobs and post your resume.

Back to news